Fortress Biotech, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Debt And Interest

Debt And Interest

3 Months Ended

Mar. 31, 2012

Debt And Interest [Abstract]

Debt And Interest

6. Debt and Interest

The $750,000 PCP Note is classified as a long-term liability at March 31, 2012 on the consolidated balance sheet.

Interest expense consisted of the following:


	For the three months ended March 31,				Period from June 28, 2006 (Date of Inception) to March 31, 2012
($ in thousands)	2012		2011
Interest expense	$	—	$	—	$	1,032
Interest expense—related parties		19		17		468
Amortization of embedded conversion feature		—		—		831
Change in fair value of Common Stock warrant liability		—		—		234
Amortization of deferred financing fees		—		—		737

Total interest expense	$	19	$	17	$	3,302

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References + Details